SL

Starling Locke Capital

Description

Starling Locke Capital operates has investment.

Investor Profile

Starling Locke Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Starling Locke Capital frequently co-invest with?

LA
Europe, Schwyz, Switzerland, Freienbach
Co-Investments: 1

What are some of recent deals done by Starling Locke Capital?

X-Therma

Richmond, California, United States

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

BiotechnologyHealth CareLife Science
Series BMar 13, 2024
Amount Raised: $22,400,000

Find More Investors Like Starling Locke Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Starling Locke Capital | Pipeseed